Professor Camillo Porta presenting at the joint ECCO 15–34th ESMO Multidisciplinary Congress.
Highlights from the official F. Hoffmann-La Roche satellite symposium of the joint ECCO 15–34th ESMO Multidisciplinary Congress ‘Innovation in cancer: anti-angiogenesis as the key to cancer care’, which took place on Sunday 20 September 2009.
Watch Professor Camillo Porta present the latest clinical trial data on the efficacy of first-line Avastin plus interferon in metastatic RCC.
- Disclaimer: Avastin.net is a comprehensive resource for healthcare professionals outside the US. If you are a US resident please visit www.avastin.comThe information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.
- © 2010 F. Hoffmann-La Roche Ltd.